April 12, 2023 Mayo Clinic Collaborates with Naveris to Advance Precision Medicine in HPV-driven Head and Neck Cancer Read
March 8, 2023 Theramex enters into an exclusive licensing agreement with Radius Health Inc, to commercialise ELADYNOS® Read
January 30, 2023 Teijin Pharma to Launch Japan-market Sales of Abaloparatide Acetate for Osteoporosis Read
December 20, 2022 TYMLOS® (abaloparatide) Receives U.S. FDA Approval for Increase Bone Density in Men with Osteoporosis Read
